Publicaciones en las que colabora con Carlos Manuel Gamazo de la Rasilla (16)

2012

  1. Nanoparticles and microparticles for allergen immunotherapy

    Journal of investigational allergology & clinical immunology, Vol. 22, Núm. suppl. 1, pp. 7-15

2011

  1. Nanomedicine: Novel approaches in human and veterinary therapeutics

    Veterinary Parasitology, Vol. 180, Núm. 1-2, pp. 47-71

2010

  1. Poly(anhydride) nanoparticles as adjuvants for mucosal vaccination

    Frontiers in Bioscience - Scholar, Vol. 2 S, Núm. 3, pp. 876-890

2009

  1. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne

    Journal of Immunological Methods, Vol. 348, Núm. 1-2, pp. 1-8

  2. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis

    International Archives of Allergy and Immunology, Vol. 149, Núm. 2, pp. 111-118

2008

  1. Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 3, pp. 711-717

  2. Applications of particulate drug delivery systems in the control of an intracellular bacterial pathogen

    Handbook of particulate drug delivery (American Scientific Publishers), pp. 325-346

  3. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 1, pp. 98-108

  4. Mannose-targeted systems for the delivery of therapeutics

    Expert Opinion on Drug Delivery, Vol. 5, Núm. 6, pp. 703-724

2007

  1. Gamma interferon loaded onto albumin nanoparticles: In vitro and in vivo activities against Brucella abortus

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 4, pp. 1310-1314

  2. Intradermal immunization with ovalbumin-loaded poly-ε-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice

    Clinical and Experimental Allergy, Vol. 37, Núm. 2, pp. 287-295

  3. Nanoparticles as adjuvant-vectors for vaccination

    Nanoparticulate Drug Delivery Systems (CRC Press), pp. 317-325

2005

  1. Synthetic particulate antigen delivery systems for vaccination

    Inmunologia, Vol. 24, Núm. 2, pp. 208-223

2003

  1. Polymeric carriers for amphotericin B: In vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 3, pp. 419-427

2001

  1. Controlled liberation of active principles by means of new galenic formulations

    Revista de medicina de la Universidad de Navarra, Vol. 45, Núm. 4, pp. 19-34

1997

  1. Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity

    International Journal of Pharmaceutics, Vol. 158, Núm. 1, pp. 19-27